These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4577881)

  • 1. Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant.
    Ziegler EJ; Douglas H; Sherman JE; Davis CE; Braude AI
    J Immunol; 1973 Aug; 111(2):433-8. PubMed ID: 4577881
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum.
    Ziegler EJ; McCutchan JA; Douglas H; Braude AI
    Trans Assoc Am Physicians; 1975; 88():101-8. PubMed ID: 772922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli and Klebsiella vaccines and immunotherapy.
    Cross AS; Sadoff JC; Furer E; Cryz SJ
    Infect Dis Clin North Am; 1990 Jun; 4(2):271-82. PubMed ID: 2189000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization against nosocomial infection.
    Braude AI; Ziegler EJ; McCutchan JA; Douglas H
    Am J Med; 1981 Feb; 70(2):463-6. PubMed ID: 7008592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental gram-negative bacterial sepsis: reevaluation of the ability of rough mutant antisera to protect mice.
    Greisman SE; DuBuy JB; Woodward CL
    Proc Soc Exp Biol Med; 1978 Jul; 158(3):482-90. PubMed ID: 356058
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular structure of the NADH/UDP-glucose abortive complex of UDP-galactose 4-epimerase from Escherichia coli: implications for the catalytic mechanism.
    Thoden JB; Frey PA; Holden HM
    Biochemistry; 1996 Apr; 35(16):5137-44. PubMed ID: 8611497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive inhibition and substrate activity of uridine diphosphate 6-deoxygalactose for Escherichia coli uridine diphosphate galactose 4-epimerase.
    Spencer M; Blackburn P; Ferdinand W; Blackburn GM
    Biochem J; 1973 Feb; 131(2):421-3. PubMed ID: 4578944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of gram-negative bacteremia with antiserum to mutant E. coli.
    Tierney WM
    N Engl J Med; 1983 Apr; 308(17):1032. PubMed ID: 6339930
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural analysis of UDP-sugar binding to UDP-galactose 4-epimerase from Escherichia coli.
    Thoden JB; Hegeman AD; Wesenberg G; Chapeau MC; Frey PA; Holden HM
    Biochemistry; 1997 May; 36(21):6294-304. PubMed ID: 9174344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of gram-negative bacteremia with antiserum to core glycolipid. I. The experimental basis of immunity to endotoxin.
    Ziegler EJ; McCutchan JA; Braude AI
    Eur J Cancer (1965); 1979; 15 Suppl():71-6. PubMed ID: 397063
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-reactive antibody in immunity to colisepticemia in calves.
    Wickstrom ML; Gay CC; Hodgson JL; Widders PR; Schaeffer D; Lee R; Corbeil LB
    Vet Microbiol; 1987 Mar; 13(3):259-71. PubMed ID: 3310376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic differences in the binding of UDP-galactose and UDP-glucose to UDP-galactose 4-epimerase from Escherichia coli.
    Thoden JB; Holden HM
    Biochemistry; 1998 Aug; 37(33):11469-77. PubMed ID: 9708982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of UDP-GlcNAc/Glc 4-epimerase from Escherichia coli O86:B7.
    Guo H; Li L; Wang PG
    Biochemistry; 2006 Nov; 45(46):13760-8. PubMed ID: 17105195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.
    Braude AI; Ziegler EJ; Douglas H; McCutchan JA
    J Infect Dis; 1977 Aug; 136 Suppl():S167-73. PubMed ID: 330776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota.
    Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D
    Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UDP-N-acetyl-D-glucosamine 2'-epimerase from Escherichia coli.
    Kawamura T; Ishimoto N; Ito E
    Methods Enzymol; 1982; 83():515-9. PubMed ID: 7048002
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activity of UDP-glucose-pyrophosphorylase and UDP-glucose-4-epimerase during differentiation of Physarum polycephalum].
    Hüttermann A
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1529. PubMed ID: 4675335
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoprophylaxis of gram-negative infections: background for a prophylactic study of purified anticore-glycolipid immunoglobulins in neutropenic patients.
    Glauser MP
    Schweiz Med Wochenschr Suppl; 1983; 14():35-9. PubMed ID: 6361989
    [No Abstract]   [Full Text] [Related]  

  • 19. [Usefulness of exchange transfusions in the treatment of septicemia complicated by intravascular coagulation in newborn infants].
    Norska-Borówka I; Grzywna W; Monsiol A; Karczewska K; Godula-Stuglik U
    Pediatr Pol; 1980 Aug; 55(8):943-9. PubMed ID: 7001329
    [No Abstract]   [Full Text] [Related]  

  • 20. Localization of translation initiation in the message for E. coli UDP-galactose 4-epimerase: the amino terminal sequence.
    Schlesinger DH; Niall HD; Wilson D
    Biochem Biophys Res Commun; 1974 Nov; 61(1):282-9. PubMed ID: 4613352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.